Drug intelligence / Profile preview

18F-PGM028299

Development stage
Preclinical
Lead developer
Takeda
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Positron Emitters → Radiopharmaceuticals, Small Molecules
Administration
Intravenous
01

Overview

18F-PGM028299 is a fluorine-18 labeled small molecule radiotracer designed for positron emission tomography (PET) imaging of D-amino-acid oxidase (DAAO) in the brain. Developed by Takeda and Perceptive Discovery (formerly Imanova), the tracer is used to evaluate DAAO distribution and measure enzyme occupancy by therapeutic DAAO inhibitors, such as luvadaxistat, in the central nervous system. Preclinical studies in rodents demonstrate rapid brain entry with high uptake in the cerebellum and brainstem, reversible pharmacokinetics, and dose-dependent displacement by DAAO inhibitors, supporting its potential clinical translation for quantitative DAAO imaging in neuropsychiatric disorders like schizophrenia.

Other names
[18F]2[18F]PGM028299
02

Targets

DAO (D-amino-acid oxidase)

Beyond the preview

Go deeper on 18F-PGM028299.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 18F-PGM028299.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call